高内部去抑制个体的减肥干预：基于接受的行为干预（ABBI）随机对照试验的设计。
Weight loss intervention for individuals with high internal disinhibition: design of the Acceptance Based Behavioral Intervention (ABBI) randomized controlled trial.
机构信息
The Miriam Hospital, Brown Medical School, Providence, USA ; Weight Control and Diabetes Research Center, The Miriam Hospital, Brown Medical School, 196 Richmond Street, Providence, RI 02903 USA.
University of Wisconsin, Whitewater, USA.
出版信息
BMC Psychol. 2015 May 28;3(1):17. doi: 10.1186/s40359-015-0075-2. eCollection 2015.
BACKGROUND
Obesity is public health problem associated with significant health risks and healthcare costs. Behavioral weight control programs produce clinically meaningful weight losses, however outcomes have high variability and maintenance continues to be a problem. The current study is an NIH-funded randomized clinical trial testing a novel approach, Acceptance-Based Behavioral Intervention (ABBI), that combines techniques from standard behavioral treatment (SBT) and Acceptance and Commitment Therapy (ACT). We test this approach among individuals reporting high internal disinhibition who typically respond poorly to standard interventions and appear to benefit from ACT components.
METHODS/DESIGN: The ABBI study targets recruitment of 160 overweight or obese adults (BMI of 25-50) who report that they overeat in response to negative emotional states. These individuals are randomly assigned to either (1) ABBI or (2) SBT. Both interventions involve weekly meetings for 22 sessions, bi-weekly for 6 sessions, and then monthly for 3 sessions and both receive the same calorie intake target (1200-1800, depending on starting weight), exercise goal (work up to 250 min per week), and self-monitoring skills training. SBT incorporates current best practice interventions for addressing problematic thoughts and emotions, sometimes called "change" or "control" strategies. ABBI uses acceptance-based techniques based on ACT. Full assessments occur at baseline, 6, 12, and 18 months. Weight loss from baseline to 18 months is the primary outcome.
DISCUSSION
The ABBI study is unique in its focus on integrating acceptance-based techniques into a SBT intervention and targeting a group of individuals with problems with emotional overeating who might experience particular benefit from this novel approach.
TRIAL REGISTRATION
ClinicalTrials.gov, NCT01461421 (registered October 25, 2011).
背景
肥胖是一个与重大健康风险和医疗保健成本相关的公共卫生问题。行为体重控制计划可产生具有临床意义的体重减轻，但结果具有高度可变性，并且维持仍然是一个问题。目前的研究是一项由 NIH 资助的随机临床试验，测试一种新方法，即基于接受的行为干预（ABBI），该方法结合了标准行为治疗（SBT）和接受与承诺疗法（ACT）的技术。我们在报告高度内部抑制的个体中测试这种方法，这些个体通常对标准干预反应不佳，并且似乎受益于 ACT 成分。
方法/设计：ABBI 研究的目标是招募 160 名超重或肥胖成年人（BMI 为 25-50），他们报告说他们在应对负面情绪时会暴饮暴食。这些个体被随机分配到以下两种干预措施之一：（1）ABBI 或（2）SBT。两种干预措施都包括每周会议 22 次，每两周会议 6 次，然后每月会议 3 次，都接受相同的卡路里摄入量目标（根据起始体重为 1200-1800），运动目标（每周达到 250 分钟），以及自我监测技能培训。SBT 采用目前解决有问题的思想和情绪的最佳实践干预措施，有时称为“改变”或“控制”策略。ABBI 使用基于 ACT 的基于接受的技术。基线、6、12 和 18 个月时进行全面评估。从基线到 18 个月的体重减轻是主要结果。
讨论
ABBI 研究的独特之处在于将基于接受的技术整合到 SBT 干预中，并针对一组有情绪性暴饮暴食问题的个体，他们可能会从这种新方法中获得特别的益处。
试验注册
ClinicalTrials.gov，NCT01461421（于 2011 年 10 月 25 日注册）。
Zotero 插件